Peter

Position:

Security Manager

Trading Style:

Swing Trader

About Peter

Peter proves that your day job can become your biggest trading edge. Peter is a Mental Health Nurse and a Cognitive Behavioral Therapist, although this may seem unrelated, Peter actually has a unique advantage that most traders lack. His deep medical knowledge provides him an insider perspective on biopharma stocks and clinical trial catalysts.

In 2022 Peter began trading, hoping to build extra income in addition to his salary as a nurse. Like many traders, he had a rough start, losing 70% in his first six months. Instead of quitting he stripped back his methods and returned to the basics. He studied the fundamentals and leaned into what he knew best, medicine. Focusing on what he knew best was a gamechanger. Peter has been a consistently profitable trader for 2 years now, beating both S&P 500 (SPY) and Nasdaq (QQQ) returns every time.


Peter’s Trading Expertise

Peter is a swing trader who specializes in biotech and pharmaceutical stocks. He generally focuses on stocks with upcoming catalysts and uses fundamental analysis in combination with technical analysis to follow stocks and strategize.


Outside of Trading

Outside of work and trading, Peter is with his family. He enjoys beach trips, park days, family meals, pretty much anything to do with family time. Peter says his family is the motivation for everything he does. In the evening he like to wind down by gaming on his PC to unwind after a long nursing shift.


Why Learn From Peter

Most traders don’t have the edge that Peter has and instead guess on biotech stocks. Peter understands the science behind the trials, the medications being tested, and the conditions being treated. This medical knowledge combined with his years of consistent trading, make him one of the most uniquely qualified swing traders in the Atlantic Trading community.


What Peter Does at Atlantic Trading

  • Shares live trading positions with regular updates
  • Answers member questions, particularly those relating to biopharma or biotech stocks
  • Hosts live trading sessions where he recaps trades and looks for upcoming opportunities
  • Available as a mentor in one-to-one sessions

Blogs by Peter

  • Image of "The Trader's Scorecard" blog article header
    Learn by reviewing trades correctly and follow a framework that will help you maintain consistency.

    The Trader’s Scorecard: How to Review Performance Without Emotion

    Most traders fail not because of strategy, but because they never review properly. This guide explains how to conduct structured weekly and monthly trading reviews,

    Peters Profile Image
    This is Peters profile image he specializes in swing trading with a focus on biotech and pharmaceutical stocks

    Peter

    March 31, 2026
    8 mins read

    Read Article →

  • Image of "How Professional Traders Prepare for the Week" blog article header
    Learn why weekly preparation matters for trader success and how professional traders do it.

    How Professional Traders Prepare for the Week (Not Just the Trading Day)

    Most traders focus only on daily setups. Professionals focus on weekly preparation. Learn how structured weekend reviews, macro context analysis, watchlist…

    Peters Profile Image
    This is Peters profile image he specializes in swing trading with a focus on biotech and pharmaceutical stocks

    Peter

    March 5, 2026
    6 mins read

    Read Article →

  • View All Blogs →

    Trades by Peter

    MoonLake Immunotherapeutics Logo (MLTX Logo)
    Case Study
    Alerted:
    10/13/2025
    Entry:
    $9.73
    Exit:
    19.45
    Duration:
    211 days
    MLTX has a big drop when one of their two trials did not meet topline results. These results meant a big drop for the stock. This became an opportunity to enter when the stock was low due to mass sell-offs.
    MLTX has a big drop when one of their two trials did not meet topline ...
    Capricor Therapeutics (CAPR) Logo
    Case Study
    Alerted:
    11/01/2024
    Entry:
    $2.50
    Exit:
    12.50
    Duration:
    7 days
    This trade exemplifies the power of catalyst-driven biotech plays when proper risk management is applied. The technical setup showed accumulation patterns before the FDA announcement, signaling institutional interest. A 400% gain in 7 days demonstrates why biotech catalysts remain one of the most explosive trading opportunities.
    This trade exemplifies the power of catalyst-driven biotech plays when proper risk management is applied. ...
    View All Trades →

    How we calculate win rates

    We measure win rate using closed trades only, to reflect actual performance, in the past 12 months.

    A trade is classified as:

    • Win → profit after fees

    • Loss → negative result

    • Breakeven → no gain or loss, not included

    Formula

    Win rate % = Wins ÷ (Wins + Losses) × 100

    Example

    • Wins: 89

    • Losses: 11

    Win rate = 89 ÷ (89 + 11) × 100 = 89%

    What we include

    • All trades within the past 12 months from the most recent update

    • Fees and realistic execution

    • Consistent calculation across all our traders

    What we exclude

    • Open trades (trades that are still on-going)

    • Partial updates or scaling entries

    Important

    Win rate alone does not define performance.

    For example, a trader with a lower win rate can outperform if their winning trades are larger than their losses.

    Please remember current performance does not predict or guarantee future performance. You may loose money by following our traders and trading is still very risky.